Compare GREE & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GREE | IRIX |
|---|---|---|
| Founded | 1937 | 1989 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3M | 18.2M |
| IPO Year | N/A | 1996 |
| Metric | GREE | IRIX |
|---|---|---|
| Price | $1.30 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 177.3K | 50.6K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,593,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $6.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $0.87 |
| 52 Week High | $2.42 | $1.65 |
| Indicator | GREE | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 47.68 |
| Support Level | $1.09 | $1.01 |
| Resistance Level | $1.39 | $1.18 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 42.46 | 45.00 |
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. The company has one reportable segment: The Datacenter Operations segment, that derives revenue through datacenter hosting, crypto-currency self-mining, and power and capacity sales. It owns and operate a vertically integrated cryptocurrency datacenter and power generation facility in Torrey, New York, which includes a natural gas power generation plant of nameplate capacity. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers owned or leased by the company.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.